Skip to content
value.today

Provista Diagnostics Inc.

🇺🇸 Phoenix, Arizona, USABiotechnologyFounded 2009
Total raised
$42 M
9 rounds on record
Latest round
$2 M
May 2018
First round on record
Feb 2012
Today
Private
No later event on record

Funding rounds

9 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Provista Diagnostics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2018$2 MNo. 9$2 to $10 million

Provista Diagnostics Inc.: Raise no. 9, May 2018

Investors in this round

6 investors had bought by the notice of May 22, 2018: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gary Altman · Executive Officer, Director
  • John G. Fermanis · Executive Officer
  • Rao G. Mulpuri · Executive Officer
  • Uriel E. Kusiatin · Executive Officer
  • Cynthia E. Collins · Director
  • Jack J. Levine · Director
  • Jeffrey R. Gilman · Director
  • John G. Zicarelli · Director
  • John J. Macaskill · Director
  • Robert J. Hariri · Director
  • Thomas G. Mendell · Director
  • Yoji G. Nimura · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Issuer is offering up to $5,000,000 in principal amount of convertible notes. This Form D is also intended to cover the underlying equity securities. A portion of the total amount sold was funded by cancellation of indebtedness and a note exchange.”

Signed by Uriel E. Kusiatin, Chief Financial Officer. Source: SEC Form D, newest notice filed May 22, 2018. Read the notice at the SEC.

equity, debtSEC
Jul 2017$2 MNo. 8$2 to $10 million

Provista Diagnostics Inc.: Raise no. 8, Jul 2017

Investors in this round

28 investors had bought by the notice of Sep 15, 2017: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Reese · Executive Officer, Director
  • Uriel E. Kusiatin · Executive Officer
  • Anne E. Busquet · Director
  • Jack E. Levine · Director
  • Jeffrey E. Gilman · Director
  • John E. Macaskill · Director
  • John E. Zicarelli · Director
  • Robert E. Hariri · Director
  • Thomas E. Mendell · Director
  • Yoji E. Nimura · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Issuer is offering up to $4,000,000 in principal amount of convertible promissory notes. This Form D is also intended to cover the underlying equity securities.”

Signed by Uriel E. Kusiatin, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 15, 2017. Read the notice at the SEC.

equity, debtSEC
Oct 2016$3 MNo. 7$2 to $10 million

Provista Diagnostics Inc.: Raise no. 7, Oct 2016

Investors in this round

5 investors had bought by the notice of Oct 26, 2016: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $6 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Reese · Executive Officer, Director
  • Uriel E. Kusiatin · Executive Officer
  • Anne E. Busquet · Director
  • Jack E. Levine · Director
  • Jeffrey E. Gilman · Director
  • John E. Macaskill · Director
  • John E. Zicarelli · Director
  • Robert E. Hariri · Director
  • Thomas E. Mendell · Director
  • Yoji E. Nimura · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Issuer is offering up to $6,000,000 in principal amount of convertible promissory notes. This Form D is also intended to cover the underlying equity securities.”

Signed by Uriel E. Kusiatin, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 26, 2016. Read the notice at the SEC.

equity, debtSEC
Mar 2016$5 MNo. 6$2 to $10 million

Provista Diagnostics Inc.: Raise no. 6, Mar 2016

Investors in this round

25 investors had bought by the notice of Mar 18, 2016: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$862
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Reese · Executive Officer, Director
  • Uriel Kusiatin · Executive Officer
  • Anne Busquet · Director
  • Jack Levine · Director
  • Jeffrey Gilman · Director
  • John Macaskill · Director
  • John Zicarelli · Director
  • Robert Hariri · Director
  • Thomas Mendell · Director
  • Yoji Nimura · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Uriel E Kusiatin, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 18, 2016. Read the notice at the SEC.

equitySEC
Jul 2015$6 MNo. 5$2 to $10 million

Provista Diagnostics Inc.: Raise no. 5, Jul 2015

Investors in this round

27 investors had bought by the notice of Aug 3, 2015: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$261
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Reese · Executive Officer, Director
  • John Fermanis · Executive Officer
  • Anne Busquet · Director
  • Jack Levine · Director
  • Jeffrey Gilman · Director
  • John Macaskill · Director
  • John Zicarelli · Director
  • Robert Hariri · Director
  • Thomas Mendell · Director
  • Yoji Nimura · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Fermanis, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 3, 2015. Read the notice at the SEC.

equitySEC
Feb 2015$4 MNo. 4$2 to $10 million

Provista Diagnostics Inc.: Raise no. 4, Feb 2015

Investors in this round

24 investors had bought by the notice of Mar 16, 2015: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$20,162
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Reese · Executive Officer, Director
  • John Fermanis · Executive Officer
  • Anne Busquet · Director
  • Jack Levine · Director
  • Jeffrey Gilman · Director
  • John Macaskill · Director
  • John Zicarelli · Director
  • Robert Hariri · Director
  • Thomas Mendell · Director
  • Yoji Nimura · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Fermanis, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 16, 2015. Read the notice at the SEC.

equitySEC
Apr 2014$6 MNo. 3$2 to $10 million

Provista Diagnostics Inc.: Raise no. 3, Apr 2014

Investors in this round

34 investors had bought by the notice of Apr 17, 2014: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$920
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Reese · Executive Officer, Director
  • John Fermanis · Executive Officer
  • Anne Busquet · Director
  • Jack Levine · Director
  • Jeffrey Gilman · Director
  • John Macaskill · Director
  • John Zicarelli · Director
  • Robert Hariri · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Fermanis, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 17, 2014. Read the notice at the SEC.

equity, optionsSEC
Apr 2013$6 MNo. 2$2 to $10 million

Provista Diagnostics Inc.: Raise no. 2, Apr 2013

Investors in this round

35 investors had bought by the notice of Apr 24, 2013: 35 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$324
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Reese · Executive Officer, Director
  • John Fermanis · Executive Officer
  • Anne Busquet · Director
  • Jack Levine · Director
  • Jeffrey Gilman · Director
  • John Macaskill · Director
  • John Zicarelli · Director
  • Robert Hariri · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Fermanis, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 24, 2013. Read the notice at the SEC.

equity, optionsSEC
Feb 2012$7 MNo. 1$2 to $10 million

Provista Diagnostics Inc.: Raise no. 1, Feb 2012

Investors in this round

32 investors had bought by the notice of Sep 21, 2012: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
$1,652
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$52,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Reese · Executive Officer, Director · President and Chief Executive Officer
  • John Fermanis · Executive Officer · Chief Financial Officer
  • Anne Busquet · Director
  • Jack Levine · Director
  • Jeffrey Gilman · Director
  • John Macaskill · Director
  • John Zicarelli · Director
  • Robert Hariri · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Note repayment to an entity controlled by a director.”

Signed by John N. Fermanis, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 21, 2012. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Provista Diagnostics Inc. chose not to state its revenue in its newest notice of a funding round (May 2018).

    SEC Form D · May 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2018

That is all the official record says: Provista Diagnostics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Provista Diagnostics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 9 rounds above had up to 35 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Provista Diagnostics Inc.
NameRoleNamed in
Gary AltmanExecutive officerMay 2018
John G. FermanisExecutive officerMay 2018
Rao G. MulpuriExecutive officerMay 2018
Uriel E. KusiatinExecutive officerMay 2018
David ReeseExecutive officerSep 2017
Uriel KusiatinExecutive officerMar 2016
John FermanisExecutive officerAug 2015
William GartnerExecutive Vice PresidentMar 2012
Cynthia E. CollinsDirectorMay 2018
Gary AltmanDirectorMay 2018
Jack J. LevineDirectorMay 2018
Jeffrey R. GilmanDirectorMay 2018
John G. ZicarelliDirectorMay 2018
John J. MacaskillDirectorMay 2018
Robert J. HaririDirectorMay 2018
Thomas G. MendellDirectorMay 2018
Yoji G. NimuraDirectorMay 2018
Anne E. BusquetDirectorSep 2017
David ReeseDirectorSep 2017
Jack E. LevineDirectorSep 2017
Jeffrey E. GilmanDirectorSep 2017
John E. MacaskillDirectorSep 2017
John E. ZicarelliDirectorSep 2017
Robert E. HaririDirectorSep 2017
Thomas E. MendellDirectorSep 2017
Yoji E. NimuraDirectorSep 2017
Anne BusquetDirectorMar 2016
Jack LevineDirectorMar 2016
Jeffrey GilmanDirectorMar 2016
John MacaskillDirectorMar 2016
John ZicarelliDirectorMar 2016
Robert HaririDirectorMar 2016
Thomas MendellDirectorMar 2016
Yoji NimuraDirectorMar 2016